Active Public Health & Healthcare Pregnancy, Children & Inherited Conditions

Greener Trials: Building the evidence base to improve the environmental sustainability of healthcare and healthcare research

In plain English

AI plain-English summary

Clinical trials are generating thousands of tonnes of carbon dioxide each year, and researchers now want to measure and shrink that footprint systematically. The problem is that no standard, widely adopted method exists for calculating the environmental cost of a clinical trial. Public and private sector organisations have begun collaborating on a common footprinting approach, but trials are governed, funded, and managed differently across sectors. This means the existing tools and guidance need to be adapted and tested for each community before their results can be combined to identify shared hotspots and effective mitigation strategies. Alongside the carbon accounting, the team will study the human behaviours that either support or block change—turning a technical fix into a lasting shift in research culture. If this succeeds, the project will produce an open online interface that makes the footprinting methodology, a calculator, and a global dataset freely available to all trial communities. That would allow funders, universities, and pharmaceutical companies to compare emissions across studies, spot the biggest sources of waste, and redesign trial protocols to be less carbon-intensive. The work does not promise a cure or a new device, but it could quietly reshape how medical research is planned and run—reducing its climate impact without compromising its scientific value.

View original technical description
A coordinated, interdisciplinary, open science approach to quantifying and reducing the carbon footprint of clinical trials is proposed. Researchers are recognising the imperative to reduce the environmental impact of their studies, but need accessible, appropriate resources to facilitate this. Public and commercial sector organisations have collaborated to develop a common method for footprinting trials. However, differences between sectors in how trials are governed, funded and managed means we need to gather more data, using guidance and tools fit for each community, to meet the ultimate aim of combining knowledge around common hotspots and mitigation strategies. Alongside carbon footprinting, we will conduct research to understand the behaviours that will support or form barriers to change, meaning the work proposed will embed tools into a more environmentally sustainable research culture. We envisage the creation of an online interface to support the published carbon footprinting guidance which will: (1) foster greater regional and inter-sector collaboration; (2) ensure that global standards and a minimum dataset are considered and established during development; (3) encourage development of global and focused communities of practice to share and learn in partnership; and (4) provide accessibility globally, for all trial communities, to the methodology, calculator and dataset.

View the original record at the funder ↗

Researchers

Beatriz Goulao (EPMC Awardee)Katie Gillies (EPMC Awardee)Lisa Fox (EPMC Awardee)Paula Williamson (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Development and prototype testing of a method to quantify the carbon footprint of current clinical trials to inform future lower carbon trial design.
Understanding current thinking around assessment of environmental impact and clinical trials regulation
Changing behaviour to enable design and delivery of greener trials?
Developing environmentally sustainable best practices for human brain imaging
Developing environmentally sustainable operating theatres

Original classification

Discretionary Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.